Apixaban/dabigatran-etexilate/rivaroxabanMajor and minor bleeding: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1883卷 / 1期

关键词：

D O I：

10.1007/s40278-021-06014-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：59 / 59

相关论文

共 50 条

[1] Apixaban/dabigatran-etexilate/rivaroxabanExcessive bleeding : 3 case reports
Reactions Weekly, 2022, 1920 (1) : 80 - 80
[2] Apixaban/dabigatran etexilate/rivaroxabanMajor bleeding: 4 case reports
Reactions Weekly, 2018, 1692 (1) : 53 - 53
[3] Apixaban/dabigatran etexilate/rivaroxabanMajor bleeding and kidney dyfunction: 3 case reports
Reactions Weekly, 2023, 1961 (1) : 68 - 68
[4] Aspirin/dabigatran-etexilate/meloxicam/rivaroxabanMajor bleedings: 13 case reports
Reactions Weekly, 2015, 1579 (1) : 61 - 61
[5] Apixaban/dabigatran-etexilate/warfarinBleeding: 4 case reports
Reactions Weekly, 2021, 1837 (1) : 82 - 82
[6] Apixaban/dabigatran-etexilate/rivaroxabanBleeding and lack of efficacy: 3 case reports
Reactions Weekly, 2024, 2028 (1) : 69 - 69
[7] Apixaban/dabigatran-etexilate/warfarinMajor bleeding, pulmonary embolism and thromboembolic event: 3 case reports
Reactions Weekly, 2022, 1909 (1) : 89 - 89
[8] Apixaban/dabigatran-etexilate/rivaroxabanMelena and symptomatic anaemia secondary to major bleeding: 3 case reports
Reactions Weekly, 2018, 1708 (1) : 57 - 57
[9] Apixaban/dabigatran-etexilate/rivaroxabanVarious toxicities: 4 case reports
Reactions Weekly, 2022, 1931 (1) : 101 - 101
[10] Apixaban/dabigatran-etexilate/rivaroxabanVarious toxicities: 8 case reports
Reactions Weekly, 2019, 1776 (1) : 78 - 78

← 1 2 3 4 5 →